Dendritic cells have the option to express IDO-mediated suppression or not - PubMed (original) (raw)

Comparative Study

. 2005 Mar 15;105(6):2618.

doi: 10.1182/blood-2005-01-0122.

• PMID: 15746089
• DOI: 10.1182/blood-2005-01-0122

Free article

Comparative Study

Dendritic cells have the option to express IDO-mediated suppression or not

David H Munn et al. Blood. 2005.

Free article

No abstract available

PubMed Disclaimer

Comment on

• Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?
  Terness P, Chuang JJ, Bauer T, Jiga L, Opelz G. Terness P, et al. Blood. 2005 Mar 15;105(6):2480-6. doi: 10.1182/blood-2004-06-2103. Epub 2004 Nov 30. Blood. 2005. PMID: 15572592

Similar articles

• Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?
  Terness P, Chuang JJ, Bauer T, Jiga L, Opelz G. Terness P, et al. Blood. 2005 Mar 15;105(6):2480-6. doi: 10.1182/blood-2004-06-2103. Epub 2004 Nov 30. Blood. 2005. PMID: 15572592
• Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells.
  Jeong YI, Kim SW, Jung ID, Lee JS, Chang JH, Lee CM, Chun SH, Yoon MS, Kim GT, Ryu SW, Kim JS, Shin YK, Lee WS, Shin HK, Lee JD, Park YM. Jeong YI, et al. J Biol Chem. 2009 Feb 6;284(6):3700-8. doi: 10.1074/jbc.M807328200. Epub 2008 Dec 15. J Biol Chem. 2009. PMID: 19075017
• Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation.
  Tas SW, Vervoordeldonk MJ, Hajji N, Schuitemaker JH, van der Sluijs KF, May MJ, Ghosh S, Kapsenberg ML, Tak PP, de Jong EC. Tas SW, et al. Blood. 2007 Sep 1;110(5):1540-9. doi: 10.1182/blood-2006-11-056010. Epub 2007 May 4. Blood. 2007. PMID: 17483297
• Tryptophan catabolism in IDO+ plasmacytoid dendritic cells.
  Fallarino F, Gizzi S, Mosci P, Grohmann U, Puccetti P. Fallarino F, et al. Curr Drug Metab. 2007 Apr;8(3):209-16. doi: 10.2174/138920007780362581. Curr Drug Metab. 2007. PMID: 17430109 Review.
• The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus.
  Abram DM, Fernandes LGR, Ramos Filho ACS, Simioni PU. Abram DM, et al. Drug Des Devel Ther. 2017 Jul 24;11:2171-2178. doi: 10.2147/DDDT.S135367. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28769554 Free PMC article. Review.

Cited by

• Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression.
  Paul PK, Das R, Drow T, Nylen EA, de Souza AH, Wang Z, Wood MW, Davis DB, Bjorling DE, Galipeau J. Paul PK, et al. Am J Transplant. 2022 Nov;22(11):2571-2585. doi: 10.1111/ajt.17162. Epub 2022 Aug 3. Am J Transplant. 2022. PMID: 35897156 Free PMC article.
• Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications.
  Cagliani J, Grande D, Molmenti EP, Miller EJ, Rilo HLR. Cagliani J, et al. J Stem Cell Regen Biol. 2017;3(2):10.15436/2471-0598.17.022. doi: 10.15436/2471-0598.17.022. Epub 2017 Apr 10. J Stem Cell Regen Biol. 2017. PMID: 29104965 Free PMC article.
• Targeting the indoleamine 2,3-dioxygenase pathway in cancer.
  Moon YW, Hajjar J, Hwu P, Naing A. Moon YW, et al. J Immunother Cancer. 2015 Dec 15;3:51. doi: 10.1186/s40425-015-0094-9. eCollection 2015. J Immunother Cancer. 2015. PMID: 26674411 Free PMC article. Review.
• Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia.
  Saulep-Easton D, Vincent FB, Le Page M, Wei A, Ting SB, Croce CM, Tam C, Mackay F. Saulep-Easton D, et al. Leukemia. 2014 Oct;28(10):2005-15. doi: 10.1038/leu.2014.105. Epub 2014 Mar 18. Leukemia. 2014. PMID: 24721775 Free PMC article.
• CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk.
  Mayer E, Hölzl M, Ahmadi S, Dillinger B, Pilat N, Fuchs D, Wekerle T, Heitger A. Mayer E, et al. Int Immunopharmacol. 2013 Mar;15(3):638-45. doi: 10.1016/j.intimp.2013.02.007. Epub 2013 Feb 20. Int Immunopharmacol. 2013. PMID: 23434857 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program